Pegaptanib sodium for neovascular age-related macular degeneration: third-year safety results of the VEGF Inhibition Study in Ocular Neovascularisation (VISION) trial (Q30440705)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pegaptanib sodium for neovascular age-related macular degeneration: third-year safety results of the VEGF Inhibition Study in Ocular Neovascularisation (VISION) trial |
scientific article |
Statements
1 reference
Pegaptanib sodium for neovascular age-related macular degeneration: third-year safety results of the VEGF Inhibition Study in Ocular Neovascularisation (VISION) trial (English)
1 reference
L J Singerman
1 reference
H Masonson
1 reference
M Patel
1 reference
A P Adamis
1 reference
R Buggage
1 reference
E Cunningham
1 reference
M Goldbaum
1 reference
B Katz
1 reference
D Guyer
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference